All In MedTech

Device Trial Radar · NCT03720171

e-OPRA Implant System for Lower Limb Amputees

An Osseointegrated Transfemoral Prosthesis Study Evaluating Stable Neural Signal Transmission in Patients With Transfemoral Amputations

Last checked: Nov 19, 2026Latest source record: May 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

2

Actual

Start

Jan 17, 2018

Primary completion

Mar 8, 2025

Study completion Mar 8, 2025

Sponsor

Lead sponsor
IntegrumNot on our public-company list
Sponsor type
Industry
Collaborators
Brigham and Women's Hospital; Massachusetts Institute of Technology
First posted
Oct 25, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The e-OPRA Implant System, is a further development of the OPRA (Osseointegrated Prostheses for the Rehabilitation of Amputees) Implant System, approved under HDE (Humanitarian Device Exemption) H080004. The e-OPRA Implant system is an implant system for direct skeletal anchorage of amputation prostheses. The added feature in the e-OPRA Implant system, is a bidirectional interface into the human body that allows permanent and reliable communication using implanted electrodes. These electrodes will provide long-term stable bioelectric signals for an improved control of the prosthetic limb. The purpose of the study is to evaluate the feasibility of a lower limb amputee with the e-OPRA Implant System exhibiting full neural control over a neuro-mechanical prosthetic system. A maximum of six subjects will be enrolled. Each subject will undergo a surgery where the e-OPRA Implant System will be implanted. The subjects will participate in follow-up sessions of which the last one occurs approximately 24 months after the surgery. This is a prospective, non-randomized, uncontrolled study.

Conditions

  • Amputation

Interventions

  • e-OPRA Implant SystemDevice

    Implantation of e-OPRA Implant System in lower limb to be used with amputation limb prosthesis

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Electrode functionTime frame: 24 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • MIT Media Lab

    Cambridge, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.